157 related articles for article (PubMed ID: 17010607)
1. Xanthine mimetics as potent dipeptidyl peptidase IV inhibitors.
Kurukulasuriya R; Rohde JJ; Szczepankiewicz BG; Basha F; Lai C; Jae HS; Winn M; Stewart KD; Longenecker KL; Lubben TW; Ballaron SJ; Sham HL; von Geldern TW
Bioorg Med Chem Lett; 2006 Dec; 16(24):6226-30. PubMed ID: 17010607
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, SAR, and X-ray structure of novel potent DPPIV inhibitors: oxadiazolyl ketones.
Koo KD; Kim MJ; Kim S; Kim KH; Hong SY; Hur GC; Yim HJ; Kim GT; Han HO; Kwon OH; Kwon TS; Koh JS; Lee CS
Bioorg Med Chem Lett; 2007 Aug; 17(15):4167-72. PubMed ID: 17544668
[TBL] [Abstract][Full Text] [Related]
3. Discovery of potent, selective, and orally bioavailable oxadiazole-based dipeptidyl peptidase IV inhibitors.
Xu J; Wei L; Mathvink RJ; Edmondson SD; Eiermann GJ; He H; Leone JF; Leiting B; Lyons KA; Marsilio F; Patel RA; Patel SB; Petrov A; Scapin G; Wu JK; Thornberry NA; Weber AE
Bioorg Med Chem Lett; 2006 Oct; 16(20):5373-7. PubMed ID: 16919457
[TBL] [Abstract][Full Text] [Related]
4. (3R,4S)-4-(2,4,5-Trifluorophenyl)-pyrrolidin-3-ylamine inhibitors of dipeptidyl peptidase IV: synthesis, in vitro, in vivo, and X-ray crystallographic characterization.
Wright SW; Ammirati MJ; Andrews KM; Brodeur AM; Danley DE; Doran SD; Lillquist JS; Liu S; McClure LD; McPherson RK; Olson TV; Orena SJ; Parker JC; Rocke BN; Soeller WC; Soglia CB; Treadway JL; Vanvolkenburg MA; Zhao Z; Cox ED
Bioorg Med Chem Lett; 2007 Oct; 17(20):5638-42. PubMed ID: 17822893
[TBL] [Abstract][Full Text] [Related]
5. Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors.
Qiao L; Baumann CA; Crysler CS; Ninan NS; Abad MC; Spurlino JC; Desjarlais RL; Kervinen J; Neeper MP; Bayoumy SS; Williams R; Deckman IC; Dasgupta M; Reed RL; Huebert ND; Tomczuk BE; Moriarty KJ
Bioorg Med Chem Lett; 2006 Jan; 16(1):123-8. PubMed ID: 16236500
[TBL] [Abstract][Full Text] [Related]
6. Discovery of non-covalent dipeptidyl peptidase IV inhibitors which induce a conformational change in the active site.
Sheehan SM; Mest HJ; Watson BM; Klimkowski VJ; Timm DE; Cauvin A; Parsons SH; Shi Q; Canada EJ; Wiley MR; Ruehter G; Evers B; Petersen S; Blaszczak LC; Pulley SR; Margolis BJ; Wishart GN; Renson B; Hankotius D; Mohr M; Zechel JC; Michael Kalbfleisch J; Dingess-Hammond EA; Boelke A; Weichert AG
Bioorg Med Chem Lett; 2007 Mar; 17(6):1765-8. PubMed ID: 17239592
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of potent 4-fluoro-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors.
Fukushima H; Hiratate A; Takahashi M; Mikami A; Saito-Hori M; Munetomo E; Kitano K; Chonan S; Saito H; Suzuki A; Takaoka Y; Yamamoto K
Bioorg Med Chem; 2008 Apr; 16(7):4093-106. PubMed ID: 18243000
[TBL] [Abstract][Full Text] [Related]
8. Triazolopiperazine-amides as dipeptidyl peptidase IV inhibitors: close analogs of JANUVIA (sitagliptin phosphate).
Kim D; Kowalchick JE; Edmondson SD; Mastracchio A; Xu J; Eiermann GJ; Leiting B; Wu JK; Pryor KD; Patel RA; He H; Lyons KA; Thornberry NA; Weber AE
Bioorg Med Chem Lett; 2007 Jun; 17(12):3373-7. PubMed ID: 17434732
[TBL] [Abstract][Full Text] [Related]
9. 1,3-disubstituted 4-aminopiperidines as useful tools in the optimization of the 2-aminobenzo[a]quinolizine dipeptidyl peptidase IV inhibitors.
Lübbers T; Böhringer M; Gobbi L; Hennig M; Hunziker D; Kuhn B; Löffler B; Mattei P; Narquizian R; Peters JU; Ruff Y; Wessel HP; Wyss P
Bioorg Med Chem Lett; 2007 Jun; 17(11):2966-70. PubMed ID: 17418568
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of triazolopiperazine-based beta-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors.
Kowalchick JE; Leiting B; Pryor KD; Marsilio F; Wu JK; He H; Lyons KA; Eiermann GJ; Petrov A; Scapin G; Patel RA; Thornberry NA; Weber AE; Kim D
Bioorg Med Chem Lett; 2007 Nov; 17(21):5934-9. PubMed ID: 17827003
[TBL] [Abstract][Full Text] [Related]
11. 4-arylcyclohexylalanine analogs as potent, selective, and orally active inhibitors of dipeptidyl peptidase IV.
Kaelin DE; Smenton AL; Eiermann GJ; He H; Leiting B; Lyons KA; Patel RA; Patel SB; Petrov A; Scapin G; Wu JK; Thornberry NA; Weber AE; Duffy JL
Bioorg Med Chem Lett; 2007 Nov; 17(21):5806-11. PubMed ID: 17851076
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitors.
Longenecker KL; Stewart KD; Madar DJ; Jakob CG; Fry EH; Wilk S; Lin CW; Ballaron SJ; Stashko MA; Lubben TH; Yong H; Pireh D; Pei Z; Basha F; Wiedeman PE; von Geldern TW; Trevillyan JM; Stoll VS
Biochemistry; 2006 Jun; 45(24):7474-82. PubMed ID: 16768443
[TBL] [Abstract][Full Text] [Related]
13. Discovery, structure-activity relationship, and pharmacological evaluation of (5-substituted-pyrrolidinyl-2-carbonyl)-2-cyanopyrrolidines as potent dipeptidyl peptidase IV inhibitors.
Pei Z; Li X; Longenecker K; von Geldern TW; Wiedeman PE; Lubben TH; Zinker BA; Stewart K; Ballaron SJ; Stashko MA; Mika AK; Beno DW; Long M; Wells H; Kempf-Grote AJ; Madar DJ; McDermott TS; Bhagavatula L; Fickes MG; Pireh D; Solomon LR; Lake MR; Edalji R; Fry EH; Sham HL; Trevillyan JM
J Med Chem; 2006 Jun; 49(12):3520-35. PubMed ID: 16759095
[TBL] [Abstract][Full Text] [Related]
14. Novel trans-2-aryl-cyclopropylamine analogues as potent and selective dipeptidyl peptidase IV inhibitors.
Tsai TY; Hsu T; Chen CT; Cheng JH; Yeh TK; Chen X; Huang CY; Chang CN; Yeh KC; Hsieh SH; Chien CH; Chang YW; Huang CH; Huang YW; Huang CL; Wu SH; Wang MH; Lu CT; Chao YS; Jiaang WT
Bioorg Med Chem; 2009 Mar; 17(6):2388-99. PubMed ID: 19261480
[TBL] [Abstract][Full Text] [Related]
15. The crystal structure of human dipeptidyl peptidase IV (DPPIV) complex with diprotin A.
Hiramatsu H; Yamamoto A; Kyono K; Higashiyama Y; Fukushima C; Shima H; Sugiyama S; Inaka K; Shimizu R
Biol Chem; 2004 Jun; 385(6):561-4. PubMed ID: 15255191
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of new potent dipeptidyl peptidase IV inhibitors with enhanced ex vivo duration.
Kondo T; Nekado T; Sugimoto I; Ochi K; Takai S; Kinoshita A; Tajima Y; Yamamoto S; Kawabata K; Nakai H; Toda M
Bioorg Med Chem; 2007 Apr; 15(7):2631-50. PubMed ID: 17293118
[TBL] [Abstract][Full Text] [Related]
17. Diprolyl nitriles as potent dipeptidyl peptidase IV inhibitors.
Zhao G; Taunk PC; Magnin DR; Simpkins LM; Robl JA; Wang A; Robertson JG; Marcinkeviciene J; Sitkoff DF; Parker RA; Kirby MS; Hamann LG
Bioorg Med Chem Lett; 2005 Sep; 15(18):3992-5. PubMed ID: 16046120
[TBL] [Abstract][Full Text] [Related]
18. Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors.
Tsai TY; Coumar MS; Hsu T; Hsieh HP; Chien CH; Chen CT; Chang CN; Lo YK; Wu SH; Huang CY; Huang YW; Wang MH; Wu HY; Lee HJ; Chen X; Chao YS; Jiaang WT
Bioorg Med Chem Lett; 2006 Jun; 16(12):3268-72. PubMed ID: 16581245
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of potent amido- and benzyl-substituted cis-3-amino-4-(2-cyanopyrrolidide)pyrrolidinyl DPP-IV inhibitors.
Corbett JW; Dirico K; Song W; Boscoe BP; Doran SD; Boyer D; Qiu X; Ammirati M; Vanvolkenburg MA; McPherson RK; Parker JC; Cox ED
Bioorg Med Chem Lett; 2007 Dec; 17(24):6707-13. PubMed ID: 17977724
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation and structural determination of beta-aminoacyl-containing cyclic hydrazine derivatives as dipeptidyl peptidase IV (DPP-IV) inhibitors.
Ahn JH; Shin MS; Jun MA; Jung SH; Kang SK; Kim KR; Rhee SD; Kang NS; Kim SY; Sohn SK; Kim SG; Jin MS; Lee JO; Cheon HG; Kim SS
Bioorg Med Chem Lett; 2007 May; 17(9):2622-8. PubMed ID: 17331715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
